ClinConnect ClinConnect Logo
Search / Trial NCT04604418

Outcomes and Health Care Resource Utilization in Pediatric Congenital Heart Disease Patients Undergoing Non-Cardiac Procedures

Launched by BOSTON CHILDREN'S HOSPITAL · Oct 21, 2020

Trial Information

Current as of July 28, 2025

Recruiting

Keywords

Perioperative Risk Prediction Adverse Postoperative Outcomes

ClinConnect Summary

This clinical trial is studying how children with congenital heart disease (CHD) handle non-cardiac surgeries and the health care resources needed for their care. Congenital heart disease is a condition that affects the structure of the heart and is found in about 6 out of every 1,000 newborns in the U.S. As medical advances have improved survival rates, many of these children may also need other types of surgeries as they grow. The goal of this study is to gather detailed information to better understand the risks these children face during non-cardiac procedures and to identify how health care systems can best support them.

To be eligible for this trial, participants must be children aged from birth up to 21 years who have been diagnosed with congenital heart disease and are scheduled for a non-cardiac procedure, whether it’s a surgery or another type of treatment. Unfortunately, children who are having heart-related surgeries or specific heart tests won’t be included. Families participating in the trial can expect to contribute to a larger understanding of how to improve care for children with CHD, which could ultimately lead to better outcomes for future patients. The study aims to create a collaborative database that captures important details about their health care experiences.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • 1. Males or females ages birth to 21 years.
  • 2. Patients diagnosed with congenital heart disease
  • 3. Patients undergoing a noncardiac procedure (surgical or nonsurgical)
  • Exclusion Criteria:
  • 1. Patients with congenial heart disease undergoing a cardiac surgical procedure including pacemakers.
  • 2. Patients with congenital heart disease undergoing a catheterization(diagnostic or interventional) or an electrophysiology study

About Boston Children's Hospital

Boston Children's Hospital is a leading pediatric healthcare institution renowned for its commitment to advancing child health through innovative research and exceptional clinical care. As a prominent clinical trial sponsor, the hospital leverages its extensive expertise in pediatric medicine to conduct rigorous and ethically sound research studies aimed at improving treatment options and outcomes for children. With a collaborative approach that integrates cutting-edge technology and multidisciplinary teams, Boston Children's Hospital is dedicated to translating scientific discoveries into practical applications that enhance the well-being of young patients and their families.

Locations

Los Angeles, California, United States

Philadelphia, Pennsylvania, United States

Houston, Texas, United States

Nashville, Tennessee, United States

Boston, Massachusetts, United States

Norfolk, Virginia, United States

Minneapolis, Minnesota, United States

Washington, District Of Columbia, United States

Toronto, Ontario, Canada

Atlanta, Georgia, United States

Patients applied

0 patients applied

Trial Officials

Viviane Nasr, MD

Principal Investigator

Boston Children's Hospital

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials